Bluesky Facebook Reddit Email

New experimental drug may restore movement after stroke

Researchers discovered that strokes cause a chain reaction within the brain, leading to neuronal cell death. They found that blocking collagen production can prevent this damage and even restore motor function in paralyzed monkeys. The new drug KDS12025 reduces hydrogen peroxide levels and prevents the entire process from being triggered.

AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

Robot-assisted therapy can help treat stroke survivors, study finds

Researchers at UTHealth found that exoskeleton-assisted rehabilitation can be beneficial for stroke survivors, correcting impaired walking patterns and increasing motor coordination. The study used the Ekso 1.1 exoskeleton to guide patients with chronic post-stroke hemiplegia or hemiparesis in a 10-15 session training program over thre...

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Stroke and sensory rehabilitation research

Researchers investigate auditory brainstem responses for early detection of ototoxic hearing loss, as well as sensory rehabilitation methods such as obstacle avoidance training, blind rehabilitation, and constraint-induced therapy. These studies aim to minimize or prevent debilitating hearing loss and improve mobility function in indiv...

Early promise for stroke patients given levodopa and physiotherapy

A preliminary study suggests that levodopa combined with physiotherapy can improve motor recovery in stroke patients. After three weeks of treatment, the levodopa group showed a significant improvement in motor function compared to the placebo group, with an RMA score gain of 6.4 points versus 4.1 points.